May 4, 2026
A new vaccine shows 70% efficacy in preventing Lyme disease, but limitations to the clinical trials put the fate of this intervention in limbo. In this episode: Anna Durbin, an expert in experimental vaccines, explains where this vaccine shows promise, where it falls short, and what could happen next...
Apr 6, 2026
A federal judge has halted changes from the Department of Health and Human Services to the childhood immunization schedule and the Advisory Committee on Immunization Practice. In this episode: the impact of this decision and what comes next.
Sarah Despres, JD, is a lawyer with over 25 years of...
Mar 26, 2026
As policy has shifted at the federal level, state legislatures are considering a broad range of vaccine-related bills. In this episode: Jennifer Herricks and Northe Saunders of American Families for Vaccines talk about the landscape of vaccine policy, from "medical freedom" bills to those seeking...
Feb 3, 2026
For decades, the recommended immunization schedule has guided physicians through the proper administration of vaccines and empowered individuals to protect themselves against preventable diseases. But recent changes to the schedule and the overhaul of the CDC committee leading vaccine recommendations...
Jan 26, 2026
The U.S. Food and Drug Administration is responsible for reviewing the safety and effectiveness of vaccines—a job that requires deep scientific understanding as well as thoughtful regulatory judgment. In this episode: Dr. Jesse Goodman, a former top vaccine regulator and chief scientist at the FDA,...